Guggenheim Begins Coverage on Elevance Health (NYSE:ELV)
Investment analysts at Guggenheim started coverage on shares of Elevance Health (NYSE:ELV – Get Free Report) in a note issued to investors on Wednesday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $518.00 price target on the stock. Guggenheim’s price objective indicates a potential upside of 18.79% from the company’s current price. […]
Investment analysts at Guggenheim started coverage on shares of Elevance Health (NYSE:ELV – Get Free Report) in a note issued to investors on Wednesday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $518.00 price target on the stock. Guggenheim’s price objective indicates a potential upside of 18.79% from the company’s current price. […]
